Patent classifications
C07C251/86
Anti-fungals targeting the synthesis of fungal shingolipids
The present invention provides a compound having the structure: ##STR00001##
Anti-fungals compounds targeting the synthesis of fungal sphingolipids
The present invention provides a compound having the structure: ##STR00001##
and use of the compound for inhibiting the growth of or killing a fungus.
Anti-fungals compounds targeting the synthesis of fungal sphingolipids
The present invention provides a compound having the structure: ##STR00001##
and use of the compound for inhibiting the growth of or killing a fungus.
Method for detecting copper(II) ions using a hydrazone-based colorimetric sensor
Cu(II) detection in the presence of main group heavy metal ions and d-, f- and g-element interferents relies on a colorimetric chelating complex between 3-hydroxy-5-nitrobenzaldehyde-4-hydroxybenzoylhydrazone (3-HNHBH) and Cu(II). Derivatives and entrapped forms of the probe were aligned with the methods of analysis, featuring spectrophotometric, reflectometric, lateral flow, microfluidic, lab-on-paper, positional array, dynamic array, flow cytometry and tandem stage devices. A remotely operating software capable of DFT calculations predicted the observed detection limit of 0.34 μg L.sup.−1 (<5 nM) as well as high selectivity towards copper ions in the presence of competing Zn+2 and Ni+2. The probe was readily regenerated against metal complexation by using a 0.5 M HCl solution, indicating its feasibility to be a re-usable sensor for the convenient detection of copper ions in water-organic media. The influence of metal interference, pH and solvents on the selectivity and regeneration of the ligand was incorporated in an algorithm providing decision support to the analyst via smartphone, laptop and other multimedia.
Method for detecting copper(II) ions using a hydrazone-based colorimetric sensor
Cu(II) detection in the presence of main group heavy metal ions and d-, f- and g-element interferents relies on a colorimetric chelating complex between 3-hydroxy-5-nitrobenzaldehyde-4-hydroxybenzoylhydrazone (3-HNHBH) and Cu(II). Derivatives and entrapped forms of the probe were aligned with the methods of analysis, featuring spectrophotometric, reflectometric, lateral flow, microfluidic, lab-on-paper, positional array, dynamic array, flow cytometry and tandem stage devices. A remotely operating software capable of DFT calculations predicted the observed detection limit of 0.34 μg L.sup.−1 (<5 nM) as well as high selectivity towards copper ions in the presence of competing Zn+2 and Ni+2. The probe was readily regenerated against metal complexation by using a 0.5 M HCl solution, indicating its feasibility to be a re-usable sensor for the convenient detection of copper ions in water-organic media. The influence of metal interference, pH and solvents on the selectivity and regeneration of the ligand was incorporated in an algorithm providing decision support to the analyst via smartphone, laptop and other multimedia.
Photochromic hydrazone switches
Provided herein are compounds for use as photochromic molecular switches having very long thermal isomerization half-lives and switchable fluorescence properties both in solution and the solid state.
Photochromic hydrazone switches
Provided herein are compounds for use as photochromic molecular switches having very long thermal isomerization half-lives and switchable fluorescence properties both in solution and the solid state.
Drug-induced activation of the Reelin signaling system
Disclosed herein are compounds for activating the Reelin signaling system for the treatment of neurological disorders. Further provided are compounds and methods for activating a lipoprotein receptor, such as ApoER2 or VLDLR.
Use of small molecule inhibitors to KLF10 for modulation of T regulatory cells and cancer immunotherapy
The invention relates to compositions and methods for inhibiting Krüppel-like Factor 10 (KLF10) for modulation of T regulatory cells and cancer immunotherapy.
Use of small molecule inhibitors to KLF10 for modulation of T regulatory cells and cancer immunotherapy
The invention relates to compositions and methods for inhibiting Krüppel-like Factor 10 (KLF10) for modulation of T regulatory cells and cancer immunotherapy.